The -629C > A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men

Citation
G. Eiriksdottir et al., The -629C > A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men, ATHEROSCLER, 159(1), 2001, pp. 187-192
Citations number
28
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
ATHEROSCLEROSIS
ISSN journal
00219150 → ACNP
Volume
159
Issue
1
Year of publication
2001
Pages
187 - 192
Database
ISI
SICI code
0021-9150(200111)159:1<187:T->API>2.0.ZU;2-P
Abstract
The aim of this study was to examine whether the well-established effect of the common TaqIB polymorphism in intron I of the gene for cholesterol este r transfer protein (CETP) on high density lipoprotein cholesterol (HDL-C) c oncentration and increased risk of myocardial infarction (MI), could be exp lained by the recently identified - 629C > A functional polymorphism in the promoter. Non-fatal MI cases (388 male) and a control group of 794 healthy men were recruited from the 30 year long prospective Reykjavik Study. In t he healthy men the frequency of the TaqIB B2 allele was 0.47 (95% CI: 0.44- 0.50) and there was a strong allelic association with the - 629A allele (D = - 0.21, P < 0.0001), which had a frequency of 0.52 (95% CI: 0.49-0.56). B 2B2 homozygotes displayed 15% higher HDL-C levels than subjects homozygous for the BI allele (P < 0.0001). Homozygotes for the - 629A allele displayed 14% higher HDL-C concentrations than subjects homozygous for the - 629C al lele (P < 0.0001). The frequencies of the alleles associated with lower HDL -C were significantly higher in cases compared with controls, 0.59 versus 0 .53 (TaqIB B1) and 0.52 versus 0.48 (-629 C) respectively (P < 0.05 for bot h). There was a significantly higher risk for MI in B I B I homozygotes (OR = 1.44, 95% CI: 1.10 - 1. 87, P < 0.01), compared to the other genotypes c ombined. This was not observed for the CC homozygotes (OR = 1.16, 95% CI: 0 .87-1.54). In addition, homozygotes for the TaqI B2 allele experienced a fi rst MI 2 years later than men with other genotypes, 59 versus 61 years (P < 0.05). This effect was not seen for the promoter polymorphism. These resul ts strongly confirm the role of the CETP gene and the TaqIB variant as a ri sk factor for MI and suggest that another functional polymorphism is yet to be discovered in the CETP gene, that will explain the effect on MI associa ted with TaqIB observed in this study. (C) 2001 Elsevier Science Ireland Lt d. All rights reserved.